Improvement of bone disease by imiglucerase (Cerezyme) therapy in patients with skeletal manifestations of type 1 Gaucher disease: results of a 48-month longitudinal cohort study

Sims KB, Pastores GM, Weinreb NJ, Barranger J, Rosenbloom BE, Packman S, Kaplan P, Mankin H, Xavier R, Angell J, Fitzpatrick MA, Rosenthal D. Improvement of bone disease by imiglucerase (Cerezyme) therapy in patients with skeletal manifestations of type 1 Gaucher disease: results of a 48-month longi...

Descripción completa

Detalles Bibliográficos
Autores principales: Sims, KB, Pastores, GM, Weinreb, NJ, Barranger, J, Rosenbloom, BE, Packman, S, Kaplan, P, Mankin, H, Xavier, R, Angell, J, Fitzpatrick, MA, Rosenthal, D
Formato: Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2008
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2440418/
https://www.ncbi.nlm.nih.gov/pubmed/18312448
http://dx.doi.org/10.1111/j.1399-0004.2008.00978.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2440418/
https://www.ncbi.nlm.nih.gov/pubmed/18312448
http://dx.doi.org/10.1111/j.1399-0004.2008.00978.x

Ejemplares similares